| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis.
|
Cytometry
|
1983
|
6.38
|
|
2
|
Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards.
|
Cytometry
|
1983
|
2.32
|
|
3
|
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.
|
Blood
|
1981
|
1.68
|
|
4
|
Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization.
|
Cytometry
|
1983
|
1.56
|
|
5
|
Long-term storage of samples for flow cytometric DNA analysis.
|
Cytometry
|
1983
|
1.36
|
|
6
|
Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients.
|
Cancer
|
1984
|
1.21
|
|
7
|
Treatment of small-cell carcinoma of the lung monitored by sequential flow cytometric DNA analysis.
|
Cancer Res
|
1982
|
1.18
|
|
8
|
Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.
|
Lancet
|
1987
|
1.15
|
|
9
|
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
|
Ann Intern Med
|
1985
|
1.09
|
|
10
|
Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis.
|
Cancer Res
|
1980
|
1.05
|
|
11
|
Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia.
|
Acta Pathol Microbiol Scand A
|
1973
|
1.02
|
|
12
|
A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas.
|
Cancer
|
1983
|
1.02
|
|
13
|
Membrane transport of anthracyclines.
|
Pharmacol Ther
|
1982
|
1.00
|
|
14
|
Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma.
|
N Engl J Med
|
1988
|
0.99
|
|
15
|
Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSF.
|
Eur J Clin Invest
|
1992
|
0.98
|
|
16
|
Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progression.
|
Eur J Haematol
|
1989
|
0.98
|
|
17
|
Lymphoblastic lymphoma: a clinicopathologic study of 95 patients.
|
Cancer
|
1981
|
0.94
|
|
18
|
Mechanism of resistance to anthracyclines and vinca alkaloids.
|
Prog Clin Biol Res
|
1983
|
0.93
|
|
19
|
Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: results of CALGB protocol 7113.
|
Leuk Res
|
1979
|
0.91
|
|
20
|
Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.
|
Cancer
|
1988
|
0.91
|
|
21
|
Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principle.
|
Cancer Treat Rev
|
1984
|
0.89
|
|
22
|
Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan).
|
Cancer
|
1980
|
0.89
|
|
23
|
Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells.
|
Cancer Chemother Pharmacol
|
1987
|
0.88
|
|
24
|
Synchronization of the human promyelocytic cell line HL 60 by thymidine.
|
Cell Tissue Kinet
|
1986
|
0.87
|
|
25
|
Meningeal involvement in non-Hodgkin's lymphoma: symptoms, incidence, risk factors and treatment.
|
Scand J Haematol
|
1985
|
0.86
|
|
26
|
PHASE I clinical trial of an oral solution of VP-16-213.
|
Cancer Treat Rep
|
1976
|
0.84
|
|
27
|
Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors.
|
Cancer Chemother Rep
|
1972
|
0.83
|
|
28
|
Occurrence of human T cell lymphotropic virus (type I) antibodies in cutaneous T cell lymphoma.
|
J Am Acad Dermatol
|
1986
|
0.83
|
|
29
|
Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor.
|
Cancer Chemother Pharmacol
|
1992
|
0.83
|
|
30
|
Radiotherapy versus combined modality treatment of stage I and II Hodgkin's disease.
|
Cancer Treat Rep
|
1982
|
0.83
|
|
31
|
Thyroid function in malignant lymphoma.
|
Acta Med Scand
|
1977
|
0.83
|
|
32
|
Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor.
|
Eur J Haematol
|
1993
|
0.82
|
|
33
|
Fatal hepatitis following irradiation and vincristine.
|
Acta Med Scand
|
1982
|
0.82
|
|
34
|
A phase I/II study of dose and administration of non-glycosylated bacterially synthesized G-M CSF in chemotherapy-induced neutropenia in patients with non-Hodgkin's lymphomas.
|
Leuk Lymphoma
|
1992
|
0.81
|
|
35
|
The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a review.
|
Recent Results Cancer Res
|
1980
|
0.81
|
|
36
|
Effect of age on therapeutic response and survival in advanced Hodgkin's disease.
|
Cancer Treat Rep
|
1982
|
0.81
|
|
37
|
Clinical trial with mycophenolic acid (NSC-129185), a new antitumor agent.
|
Cancer Chemother Rep
|
1972
|
0.81
|
|
38
|
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B.
|
J Clin Oncol
|
1986
|
0.80
|
|
39
|
Immunohistochemical identification of lymphocyte subsets and accessory cells in human hyperplastic lymph nodes. The functional significance of the compartmentalization of lymphoid tissue.
|
Scand J Haematol
|
1984
|
0.80
|
|
40
|
Abolished production of interferon by leucocytes of patients with the acquired cytogenetic abnormalities 5q -- or -- 5 in secondary and de-novo acute non-lymphocytic leukaemia.
|
Br J Haematol
|
1980
|
0.80
|
|
41
|
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies.
|
Cancer Treat Rep
|
1982
|
0.80
|
|
42
|
Anticoagulant treatment of acute coronary thrombosis.
|
Acta Med Scand
|
1969
|
0.80
|
|
43
|
Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
|
Scand J Haematol
|
1986
|
0.79
|
|
44
|
Metabolic studies in man with mycophenolic acid (NSC-129185), a new antitumor agent.
|
Cancer Chemother Rep
|
1972
|
0.79
|
|
45
|
Prognostic factors in Hodgkin's disease stage IV.
|
Eur J Haematol
|
1988
|
0.79
|
|
46
|
Daunorubicin in the therapy of acute granulocytic leukemia.
|
Cancer Res
|
1973
|
0.79
|
|
47
|
Clinical experience with bacteraemia in patients with leukaemia and allied neoplastic diseases.
|
Chemotherapy
|
1978
|
0.78
|
|
48
|
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B.
|
Cancer
|
1993
|
0.78
|
|
49
|
Anthracycline resistance.
|
Acta Oncol
|
1989
|
0.78
|
|
50
|
Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
|
Br J Cancer
|
1993
|
0.78
|
|
51
|
Cefotaxime versus ampicillin, methicillin and netilmicin in combination for treatment of febrile episodes in patients with haematologic malignancy.
|
Acta Med Scand
|
1983
|
0.78
|
|
52
|
Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
|
Cancer Treat Rep
|
1984
|
0.78
|
|
53
|
Changes over the course of time in histological subclassification of Hodgkin's disease in Denmark.
|
Dan Med Bull
|
1991
|
0.78
|
|
54
|
Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
|
Scand J Haematol
|
1985
|
0.77
|
|
55
|
Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
|
Cancer Treat Rep
|
1977
|
0.77
|
|
56
|
Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
|
Cancer
|
1985
|
0.77
|
|
57
|
Human immunodeficiency virus (HIV) associated non-Hodgkin's lymphomas in Denmark: report of three cases.
|
Eur J Haematol
|
1987
|
0.77
|
|
58
|
A simplified working formulation of non-Hodgkin's lymphomas based on quantifiable histologic criteria.
|
Cancer
|
1989
|
0.77
|
|
59
|
Phase I trial of a new form of an oral administration of VP-16-213.
|
Cancer Treat Rep
|
1979
|
0.77
|
|
60
|
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.
|
Cancer
|
1979
|
0.77
|
|
61
|
The liver in Hodgkin's disease--II. Histopathologic findings.
|
Eur J Cancer Clin Oncol
|
1982
|
0.77
|
|
62
|
In vitro circumvention of anthracycline--resistance in Ehrlich ascites tumour by anthracycline analogues.
|
Biochem Pharmacol
|
1990
|
0.77
|
|
63
|
Modulation of neutrophil and monocyte function by recombinant human granulocyte macrophage colony-stimulating factor in patients with lymphoma.
|
Eur J Clin Invest
|
1991
|
0.77
|
|
64
|
Development and application of a sensitive radioimmunoassay for human granulocyte-macrophage colony-stimulating factor able to measure normal concentrations in blood.
|
Exp Hematol
|
1993
|
0.77
|
|
65
|
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
|
Cancer
|
1980
|
0.77
|
|
66
|
In vivo kinetics of 111indium-labelled autologous granulocytes following i.v. administration of granulocyte-macrophage colony-stimulating factor (GM-CSF).
|
Eur J Haematol
|
1992
|
0.77
|
|
67
|
Clonal evolution demonstrated by flow cytometric DNA analysis of a human colonic carcinoma grown in nude mice.
|
Exp Cell Biol
|
1982
|
0.77
|
|
68
|
Cross resistance and cellular uptake of 4'-O-methyldoxorubicin in experimental tumors with acquired resistance to doxorubicin.
|
Cancer Chemother Pharmacol
|
1981
|
0.76
|
|
69
|
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B.
|
Cancer
|
1980
|
0.76
|
|
70
|
Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213).
|
Cancer Chemother Rep
|
1972
|
0.76
|
|
71
|
Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: a study of the cancer and acute leukemia group B.
|
Cancer
|
1981
|
0.76
|
|
72
|
Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
|
Cancer
|
1978
|
0.76
|
|
73
|
Cefotaxime monotherapy in septicemic patients with hematological malignancies.
|
Clin Ther
|
1986
|
0.75
|
|
74
|
Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's disease.
|
Cancer
|
1982
|
0.75
|
|
75
|
Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy.
|
Br J Cancer
|
1987
|
0.75
|
|
76
|
Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results.
|
Cancer Treat Rep
|
1980
|
0.75
|
|
77
|
Ornithine carbamoyl transferase activity in serum. Preliminary experience with a non-isotopic method suitable for routine clinical analysis.
|
Scand J Clin Lab Invest Suppl
|
1967
|
0.75
|
|
78
|
Management of non-Hodgkin lymphoma in adults in Scandinavia, United Kingdom, and The Netherlands. Report from the European School of Oncology intercity meeting at Huddinge Hospital, 3rd June, 1988.
|
Acta Oncol
|
1989
|
0.75
|
|
79
|
[Effect of a mineral preparation on transplanted mouse tumours].
|
Ugeskr Laeger
|
1975
|
0.75
|
|
80
|
In vitro stimulation of human neutrophil granulopoiesis by unmasking an effect of human serum. Target cell specificity.
|
Scand J Haematol
|
1983
|
0.75
|
|
81
|
Expression of an antigen defined by a monoclonal antibody (SA-1) on normal and malignant cells.
|
Scand J Haematol
|
1985
|
0.75
|
|
82
|
Increased uptake of actinomycin D in Ehrlich ascites tumour cells induced by daunorubicin.
|
Cancer Chemother Pharmacol
|
1983
|
0.75
|
|
83
|
The in vivo effects of interleukin-3 on histamine levels in non-Hodgkin's lymphoma patients.
|
Pharmacol Toxicol
|
1997
|
0.75
|
|
84
|
[Malignant hematologic diseases. Diagnosis and treatment. A clearing report].
|
Ugeskr Laeger
|
1991
|
0.75
|
|
85
|
Comparative studies on spironolactone (Aldactone) and chlorthalidone (Hygroton) in the treatment of arterial hypertension.
|
Acta Med Scand
|
1966
|
0.75
|
|
86
|
Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
|
Acta Med Scand
|
1980
|
0.75
|
|
87
|
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study.
|
Cancer
|
1981
|
0.75
|
|
88
|
Automated cytochemistry in the prediction of remission following chemotherapy of patients with de novo acute myeloblastic leukemia.
|
Am J Clin Pathol
|
1982
|
0.75
|
|
89
|
Therapy-related acute nonlymphocytic leukemia of FAB type M4 or M5 with early onset and t(9;11) (p21;q23) or a normal karyotype: a separate entity?
|
J Clin Oncol
|
1988
|
0.75
|
|
90
|
Radiographic evaluation of pulmonary fibrosis following mantle field irradiation in Hodgkin's disease.
|
Acta Radiol Oncol
|
1986
|
0.75
|
|
91
|
[Lactate dehydrogenase isoenzyme patterns in serum in hematologic and neoplastic diseases].
|
Nord Med
|
1968
|
0.75
|
|
92
|
[Ultrasound and lymphography in malignant lymphoma. Comparison with consideration to staging].
|
Ugeskr Laeger
|
1994
|
0.75
|
|
93
|
Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic disease.
|
Cancer Chemother Rep
|
1976
|
0.75
|
|
94
|
Chemotherapy with or without radiotherapy in malignant lymphomas.
|
Antibiot Chemother (1971)
|
1978
|
0.75
|
|
95
|
High-risk AML evidenced by a monoclonal antibody.
|
Eur J Haematol
|
1988
|
0.75
|
|
96
|
Effects of interleukin-3 following chemotherapy of non-Hodgkin's lymphoma. A prospective, controlled phase I/II study.
|
Eur J Haematol
|
1995
|
0.75
|
|
97
|
Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
|
Arch Intern Med
|
1973
|
0.75
|
|
98
|
VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
|
Cancer Treat Rep
|
1981
|
0.75
|
|
99
|
Hodgkin's disease and age.
|
Eur J Haematol
|
1989
|
0.75
|
|
100
|
[Estrogen therapy of prostatic cancer. 76 cases of previously undiagnosed prostatic cancer treated with F6066 (bis-(p-acetoxyphenyl)cyclohexylidenemethane) and diethylstilbestrol--a double-blind study].
|
Nord Med
|
1969
|
0.75
|
|
101
|
The relative merit of various cytochemical quantities and manual differential count in predicting remission following chemotherapy of patients with de novo acute myeloblastic leukemia.
|
Am J Clin Pathol
|
1985
|
0.75
|
|
102
|
The liver in Hodgkin's disease--I. Clinico-pathological relations.
|
Eur J Cancer Clin Oncol
|
1982
|
0.75
|
|
103
|
Hodgkin's disease stages I and II with infradiaphragmatic presentation: a rare and prognostically unfavourable combination.
|
Eur J Haematol
|
1988
|
0.75
|
|
104
|
Influence of age and duration of follow-up on lung function after combined chemotherapy for Hodgkin's disease.
|
Eur Respir J
|
1990
|
0.75
|
|
105
|
High activity of mitoxantrone in previously untreated low-grade lymphomas.
|
Cancer Chemother Pharmacol
|
1988
|
0.75
|
|
106
|
[Serum-lactate dehydrogenase isoenzymes in myocardial and hepatic disease].
|
Nord Med
|
1967
|
0.75
|
|
107
|
Bacteremia and candidemia in hematological malignancies: clinical findings.
|
Scand J Infect Dis
|
1988
|
0.75
|
|
108
|
Experiences from the National Danish Hodgkin's Study Group (LYGRA) with respect to diagnosis, classification and treatment of Hodgkin's disease.
|
Acta Radiol Oncol
|
1984
|
0.75
|
|
109
|
[Rubidomycin-daunomycin therapy in acute myeloblastic leukemia].
|
Nord Med
|
1968
|
0.75
|
|
110
|
Micropore filters for sterile filtration may leach toxic compounds affecting cell cultures (HL 60).
|
Exp Hematol
|
1985
|
0.75
|
|
111
|
Clinical trial of rubidazone in solid tumors and malignant lymphomas.
|
Cancer Treat Rep
|
1978
|
0.75
|
|
112
|
[Acute non-lymphocytic leukemia (ANLL) in adults. Therapeutic criteria and their consequences].
|
Ugeskr Laeger
|
1988
|
0.75
|
|
113
|
[Chronic lymphocytic leukemia treated with herbal remedy consisting of plant extracts].
|
Ugeskr Laeger
|
1979
|
0.75
|
|
114
|
[Clinically controlled research in tumor chemotherapy].
|
Nord Med
|
1971
|
0.75
|
|
115
|
Oral idarubicin in elderly patients with acute myeloid leukemia.
|
Eur J Haematol
|
1990
|
0.75
|
|
116
|
Toxicity of intravenous catheters tested in a human bone marrow culture system.
|
Acta Med Scand
|
1977
|
0.75
|
|
117
|
Bacteraemia in patients with leukaemia and allied neoplastic diseases.
|
Scand J Infect Dis
|
1976
|
0.75
|
|
118
|
Leukemia following treatment of germ cell tumors in men.
|
J Clin Oncol
|
1985
|
0.75
|
|
119
|
Predictive value of bone marrow cultures in 48 patients with acute myeloblastic leukaemia or myelodysplasia both secondary to treatment of other malignant diseases.
|
Scand J Haematol
|
1985
|
0.75
|
|
120
|
[Drug treatment of neoplastic diseases].
|
Nord Med
|
1966
|
0.75
|
|
121
|
Immunological markers in acute leukaemia.
|
Scand J Haematol
|
1985
|
0.75
|
|
122
|
Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease. The Danish National Hodgkin Study Group.
|
Cancer
|
1990
|
0.75
|
|
123
|
[Hodgkin's disease and other malignant lymphomas].
|
Ugeskr Laeger
|
1972
|
0.75
|
|
124
|
[Vinblastine in the treatment of Hodgkin's disease].
|
Nord Med
|
1971
|
0.75
|
|
125
|
[New principles of treatment in acute leukemia].
|
Ugeskr Laeger
|
1970
|
0.75
|
|
126
|
Naproxen has greater antipyretic effect on Hodgkin's disease-related fever than no other tumours or infection.
|
Scand J Haematol
|
1985
|
0.75
|
|
127
|
Comparative studies on the diuretic and biochemical effects of prednisone and spironolactone in hepatic cirrhosis.
|
Acta Med Scand
|
1966
|
0.75
|
|
128
|
Combination chemotherapy of non-Hodgkin lymphoma.
|
Med Pediatr Oncol
|
1978
|
0.75
|
|
129
|
Studies on the antineoplastic effect of vanadium salts.
|
Acta Chir Scand Suppl
|
1965
|
0.75
|
|
130
|
[Thyroid function in malignant lymphoma].
|
Ugeskr Laeger
|
1977
|
0.75
|
|
131
|
[Phase-II-study with cis-diamminedichloroplatinum (II) in the treatment of advanced malignant lymphomas].
|
Schweiz Med Wochenschr
|
1980
|
0.75
|
|
132
|
[Serious side-effects following treatment with mistletoe extract].
|
Ugeskr Laeger
|
1983
|
0.75
|
|
133
|
Severe aplastic anaemia with complete autologous marrow reconstitution following treatment with antithymocyte globulin. Report of a case and review of the literature.
|
Scand J Haematol
|
1978
|
0.75
|
|
134
|
Non-Hodgkin malignant lymphomas and Hodgkin's disease in first-degree relatives. Evidence for a mutual genetic predisposition?
|
Scand J Haematol
|
1986
|
0.75
|
|
135
|
Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.
|
J Clin Oncol
|
1992
|
0.75
|
|
136
|
Pharmacokinetic and pharmacodynamic studies of subcutaneously administered recombinant human interleukin-3 following chemotherapy for non-Hodgkin's lymphoma.
|
Br J Haematol
|
1995
|
0.75
|
|
137
|
[Solid tumors in childhood. With special reference to cytostatic treatment].
|
Ugeskr Laeger
|
1978
|
0.75
|
|
138
|
Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease: a Cancer and Acute Leukemia Group B study.
|
Cancer
|
1979
|
0.75
|
|
139
|
Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up study.
|
Med Pediatr Oncol
|
1979
|
0.75
|
|
140
|
[Medical treatment of cancer--an elucidating report].
|
Ugeskr Laeger
|
1988
|
0.75
|
|
141
|
Mitoxantrone in the treatment of chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
1992
|
0.75
|
|
142
|
[Evaluation of the clinical effect of antineoplastic drugs].
|
Ugeskr Laeger
|
1972
|
0.75
|
|
143
|
[Vincristine sulfas (Oncovin), a cytostatic agent].
|
Ugeskr Laeger
|
1973
|
0.75
|
|
144
|
[Allopurinol treatment of hyperuricemia].
|
Nord Med
|
1967
|
0.75
|
|
145
|
Patterns of lactic acid dehydrogenase isoenzymes in normal and malignant human tissues.
|
Eur J Cancer
|
1965
|
0.75
|
|
146
|
[Letter: The anti-neoplastic effect of Scanalka].
|
Ugeskr Laeger
|
1976
|
0.75
|
|
147
|
Prognostic factors in Hodgkin's disease stage III with special reference to tumour burden.
|
Eur J Haematol
|
1988
|
0.75
|
|
148
|
[Bone marrow biopsy with Radner's needle. A new method for bone marrow examination].
|
Ugeskr Laeger
|
1974
|
0.75
|
|
149
|
1 alpha(OH)D3 (ETALPHA) treatment and receptor studies in 16 patients with chronic and myeloproliferative disorders.
|
Eur J Haematol
|
1987
|
0.75
|
|
150
|
Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.
|
Eur J Cancer
|
1976
|
0.75
|
|
151
|
The Radner needle a bone-marrow biopsy device.
|
Scand J Haematol
|
1974
|
0.75
|
|
152
|
Human immunodeficiency virus (HIV) antibody testing in 862 patients with lymphoma and leukaemia attending a department of haematology (1984-1988)
|
Eur J Haematol
|
1989
|
0.75
|
|
153
|
[Hodgkin's disease--a histologic problem].
|
Ugeskr Laeger
|
1989
|
0.75
|
|
154
|
Recombinant human interleukin-3: pharmacokinetics after intravenous and subcutaneous bolus injection and effects on granulocyte kinetics.
|
Br J Haematol
|
1994
|
0.75
|
|
155
|
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA.
|
Scand J Haematol
|
1980
|
0.75
|
|
156
|
S-phase induction by interleukin-6 followed by chemotherapy in patients with chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
|
Leuk Lymphoma
|
1999
|
0.75
|
|
157
|
[Vinca alkaloids, a newer group of anti-neoplastic drugs].
|
Ugeskr Laeger
|
1972
|
0.75
|
|
158
|
[Use of chemotherapy in combination with surgery and irradiation in cases of nephroblastoma (Wilm's tumor)].
|
Ugeskr Laeger
|
1973
|
0.75
|
|
159
|
S-phase induction by interleukin-6 followed by chemotherapy in patients with refractory multiple myeloma.
|
Leuk Res
|
1998
|
0.75
|
|
160
|
Late effects on pulmonary function of mantle-field irradiation, chemotherapy or combined modality therapy for Hodgkin's disease.
|
Eur J Haematol
|
1990
|
0.75
|
|
161
|
[Rubidomycin-daunomycin, a new antibiotic with antineoplastic effect].
|
Nord Med
|
1968
|
0.75
|
|
162
|
Adriamycin, an antitumour antibiotic: a review with special reference to daunomycin.
|
Dan Med Bull
|
1975
|
0.75
|
|
163
|
[Campath-1H--a monoclonal antibody for treatment of non-Hodgkin's and chronic lymphatic leukemia].
|
Ugeskr Laeger
|
1997
|
0.75
|